Home
Home

RSV

Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug

Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug
Yahoo/AP

News

PDL Settles MedImmune Dispute
Yahoo/Zacks.com

News

Deals to Be Done After AstraZeneca Setback
WSJ Online

News

AstraZeneca Halts Drug, Takes Big Charge
TheStreet.com

News

Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
»

News

Synagis' Special Status Under Health Care Reform
InVivo
»

News

FDA Resets Motavizumab Decision to Aug. 27
TopWireNews
»

News

AstraZeneca: FDA changes motavizumab review date
Marketwatch
»

News

AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
BNET Pharma
»

News

FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Seeking Alpha
»